Table 11. Antiviral Activities against 3CLpro and Mpro (Main Protease) of 110–115^a.

cpd	EV-A71 [μM]	CVB3 [μM]	SARS-CoV [μM]	HCoV-NL63 [μM]
110	1.22 ± 0.12	6.56 ± 3.10	1.95 ± 0.24	>50
111	13.80 ± 4.17	3.82 ± 1.21	0.33 ± 0.04	1.08 ± 0.09
112	1.69 ± 0.47	0.95 ± 0.15	0.71 ± 0.36	12.27 ± 3.56
113	18.47 ± 4.25	4.25 ± 1.40	0.24 ± 0.08	1.37 ± 0.35
114	10.81 ± 2.62	4.78 ± 1.13	1.44 ± 0.40	3.43 ± 2.45
115	4.73 ± 0.94	1.93 ± 0.43	1.27 ± 0.34	5.41 ± 2.31

^aData are taken from Zhang et al.¹⁹³